SHP2 in the cytoplasm dephosphorylates STAT1, which ultimately inhibits the proliferation of T lymphocytes, leads to a decline in antitumor immunity, and promotes the development of cancer (Liu et al., 2020). This evidence concerns the gene PTPN11 and cancer.